Study to Evaluate the Safety and Efficacy of LIPO-202 for the Reduction of Submental Subcutaneous Fat

NCT03005717 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

162

Enrollment

INDUSTRY

Sponsor class

Conditions

Submental Fat

Interventions

DRUG: LIPO-202
DRUG: Placebo for LIPO-202

Sponsor

Neothetics, Inc